Page last updated: 2024-12-08

parkeol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

parkeol: the triterpene precursor of saponins in sea cucmbers; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

parkeol : A tetracyclic triterpenoid comprised of a lanostane skeleton which is 3beta-hydroxylated and has double bonds at the 9(11)- and 24-positions. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID12313974
CHEBI ID63460
MeSH IDM0247430

Synonyms (16)

Synonym
parkeol
514-45-4
C19918
lanosta-9(11),24-dien-3beta-ol
5alpha-lanosta-9(11),24-dien-3beta-ol
delta(9(11),24)-lanostadien-3beta-ol
4,4,14alpha-trimethyl-5alpha-cholesta-9(11),24-dien-3beta-ol
CHEBI:63460
DTXSID20487430
(3s,5r,8s,10s,13r,14s,17r)-4,4,10,13,14-pentamethyl-17-[(2r)-6-methylhept-5-en-2-yl]-2,3,5,6,7,8,12,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-3-ol
Q27132633
lanosta-9(11),24-dien-3-ol, (3b)-
lanosta-9(11),24-dien-3-ol, (3beta)-
FM88E87P32
(3beta)-lanosta-9(11),24-dien-3-ol
(3s,5r,8r,10r,13r,14r,17r)-4,4,10,13,14-pentamethyl-17-((2r)-6-methylhept-5-en-2-yl)-2,3,5,6,7,8,12,15,16,17-decahydro-1h-cyclopenta(a)phenanthren-3-ol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
3beta-sterolA sterol in which the hydroxy group at position 3 has beta- configuration.
tetracyclic triterpenoidAny triterpenoid consisting of a tetracyclic skeleton.
3beta-hydroxy-4,4-dimethylsteroidAny 3beta-hydroxy steroid which is substituted by two methyl groups at position 4.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
parkeol biosynthesis12

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]